36-Month Outcomes from the Prospective GEMINI Study: Canaloplasty and Trabeculotomy Combined with Cataract Surgery for Patients with Primary Open-Angle Glaucoma.
Michael D GreenwoodArkadiy YadgarovBrian E FlowersSteven R SarkisianAfua Ohene-NyakoJaime E Dickersonnull nullPublished in: Clinical ophthalmology (Auckland, N.Z.) (2023)
GEMINI demonstrated 12-month effectiveness of canaloplasty and trabeculotomy with OMNI combined with cataract surgery for IOP and medication reduction in mild-to-moderate glaucoma. However, longer-term data is key to the decision making in the selection of a surgical treatment. This GEMINI extension demonstrates that the 12-month outcomes from GEMINI were sustained through 36 months.